Fungal fuel

Jack Newman, senior vice president of research and co-founder of biotech company Amyris, once believed algae would serve as the next biofuel. As a young postdoc in the lab of University of California, Berkeley, synthetic biologist Jay Keasling, Newman floated the idea of starting an algal biofuel company at one of the informal pitch parties Keasling would hold for his students at his house. B

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Jack Newman, senior vice president of research and co-founder of biotech company Amyris, once believed algae would serve as the next biofuel. As a young postdoc in the lab of University of California, Berkeley, synthetic biologist Jay Keasling, Newman floated the idea of starting an algal biofuel company at one of the informal pitch parties Keasling would hold for his students at his house.

But as Newman and his colleagues continued to brainstorm, they saw a major hurdle. Evolution hasn't achieved ultimate photosynthetic efficiency in plants and algae - only a small percentage of solar energy is converted to biomass - so human efforts to do so would be quixotic. "Nature's been trying to do that for billions of years," Newman says. "Wow, that's really hard."

Plus, he adds, the algal genome is a veritable black box compared to the DNA of more familiar laboratory organisms. "The timeline for introducing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide